|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002920,
umls-concept:C0026336,
umls-concept:C0027498,
umls-concept:C0032790,
umls-concept:C0033487,
umls-concept:C0063252,
umls-concept:C0063322,
umls-concept:C0199176,
umls-concept:C0205390,
umls-concept:C0220812,
umls-concept:C0278134,
umls-concept:C0439810,
umls-concept:C1441506,
umls-concept:C1511536,
umls-concept:C1707455,
umls-concept:C1707959,
umls-concept:C2348609,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-10-22
|
|
pubmed:abstractText |
Postoperative nausea and vomiting (PONV) are among the most frequent complications after general anaesthesia. Avoiding these symptoms is of utmost importance for most patients; PONV is not only a major source of discomfort for patients but also a cause of additional costs for the patients and the health care provider. The economical impact of PONV will become even more important in the near future because the number of surgical procedures performed on an ambulatory basis is increasing. The following article gives a short overview of the terminology and measures used in pharmacoeconomical studies concerning PONV. Furthermore the economical aspects of a low-flow anaesthesia supplemented with the 5-HT(3)-antagonist tropisetron compared with a total intravenous anaesthesia (TIVA) using propofol are described.
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0003-2417
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
475-81
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12391535-Adult,
pubmed-meshheading:12391535-Anesthesia, Inhalation,
pubmed-meshheading:12391535-Anesthesia, Intravenous,
pubmed-meshheading:12391535-Anesthetics, Inhalation,
pubmed-meshheading:12391535-Anesthetics, Intravenous,
pubmed-meshheading:12391535-Antiemetics,
pubmed-meshheading:12391535-Attitude,
pubmed-meshheading:12391535-Cost Control,
pubmed-meshheading:12391535-Cost-Benefit Analysis,
pubmed-meshheading:12391535-Economics, Pharmaceutical,
pubmed-meshheading:12391535-Female,
pubmed-meshheading:12391535-Gynecologic Surgical Procedures,
pubmed-meshheading:12391535-Humans,
pubmed-meshheading:12391535-Indoles,
pubmed-meshheading:12391535-Isoflurane,
pubmed-meshheading:12391535-Middle Aged,
pubmed-meshheading:12391535-Models, Economic,
pubmed-meshheading:12391535-Postoperative Nausea and Vomiting,
pubmed-meshheading:12391535-Propofol
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
[Pharmacoeconomical model for cost calculation using a study on prophylaxis of nausea and vomiting in the postoperative phase as an example. Cost effectiveness analysis of a tropisetron supplemented desflurane anaesthesia in comparison to a propofol total intravenous anaesthesia (TIVA)].
|
|
pubmed:affiliation |
Universitätsklinik für Anästhesiologie und Intensivtherapie, Philipps-Universität Marburg, Germany. eberhart@mailer.uni-marburg.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Randomized Controlled Trial
|
